Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Personalis Inc (NQ: PSNL )

3.405 +0.025 (+0.74%)
Streaming Delayed Price Updated: 11:22 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis Inc

< Previous 1 2 3 4 5 6 7 Next >
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development
From Personalis
Via Business Wire
Return on Capital Employed Insights for Personalis
Pulled from Benzinga Pro data Personalis (NASDAQ:PSNL) reported Q2 sales of $21.67 million. Earnings fell to a loss of $14.95 million, resulting in a 19.67% decrease from last... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
Recap: Personalis Q2 Earnings
Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.24% year over year to... 
Via Benzinga
Personalis Reports Second Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
From Personalis, Inc.
Via Business Wire
Personalis to Announce Second Quarter Financial Results on August 4, 2021
From Personalis, Inc.
Via Business Wire
Personalis Announces NeXT Level Biomarkers Symposium
From Personalis, Inc.
Via Business Wire
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
From Personalis, Inc.
Via Business Wire
Personalis, Inc. to Present at Biomarkers Week Online 2021
From Personalis, Inc.
Via Business Wire
Personalis Reports First Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at the 2021 Bank of America Healthcare Conference
From Personalis, Inc.
Via Business Wire
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
From Personalis, Inc.
Via Business Wire
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.